John T. Lawler
John T. Lawler is with AbbVie Inc., Small Molecule Analytical R&D Department of AbbVie Inc., in North Chicago, Illinois.
Articles
A Standardized 2D-LC Screening Platform for Peak Purity Determination in Pharmaceutical Analysis
June 1st 2023This study suggests a 2D-LC screening method to evaluate peak purity and ensure specificity in pharmaceutical analysis, thereby promoting the safe production of medicines by detecting active pharmaceutical ingredients (API) and related substances.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
Analyzing Organic Acids in Fruit-Based Kombucha Analogues Using HPLC
Published: November 18th 2024 | Updated: November 19th 2024
LC-HRMS Technology Used to Track Chemical Migration in Reusable Plastic Bottles
Published: July 3rd 2024 | Updated: July 8th 2024
Technology Trends in Separation Science: Data Handling
Published: December 19th 2024 | Updated: December 22nd 2024
Advances in Biopharmaceutical Analysis (Dec 2024)
Published: December 19th 2024 | Updated: December 22nd 2024
Advances in Biopharmaceutical Analysis EU
Published: December 4th 2024 | Updated: December 22nd 2024
Vol 20 No 12 The Column December 2024 North America PDF
